Koers | 11.70 | Hoogste koers | 13.30 |
Laagste koers | 10.80 | 1-jrs rend. | 0.86 |
Gem. Koersd. | 20.80 | Ver. Rend. | 77.78 % |
Sector | Gezondheid | Subsector | Biotechnologie |
Verkopen | 0 | Rating | |
Houden | 0 | Consensus | |
Kopen | 2 |
Jaar | Omzet | Totaal omzet sector | Marktaandeel |
---|---|---|---|
2019 | 0 | 141,925 | 0.00 % |
2020 | 0 | 170,231 | 0.00 % |
2021 | 3 | 252,886 | 0.00 % |
2022 | 3 | 238,500 | 0.00 % |
2023 | 0 | 0 | 0.00 % |
Date Label | Bank Label | Stock Label | Advice Label | Price Label | Diff Label |
---|---|---|---|---|---|
5 april 2024 | DeGroof Petercam | Hyloris | Kopen | 22.10 | 47.06 % |
19 oktober 2023 | KBC Securities | Hyloris | Kopen | 19.50 | 40.00 % |
2 mei 2023 | KBC Securities | Hyloris | Kopen | 19.50 | 38.72 % |
28 november 2022 | Berenberg | Hyloris | Kopen | 20.00 | 37.00 % |
17 juli 2022 | KBC Securities | Hyloris | Kopen | 19.50 | 43.33 % |
25 februari 2022 | KBC Securities | Hyloris | Kopen | 19.50 | 30.26 % |
17 december 2021 | KBC Securities | Hyloris | Kopen | 17.50 | 26.17 % |
13 oktober 2021 | KBC Securities | Hyloris | Kopen | 16.50 | 25.21 % |
8 oktober 2021 | KBC Securities | Hyloris | Kopen | 15.50 | 17.03 % |
4 augustus 2021 | KBC Securities | Hyloris | Kopen | 15.00 | 2.93 % |
18 mei 2021 | Berenberg | Hyloris | Kopen | 18.00 | 13.00 % |
9 maart 2021 | KBC Securities | Hyloris | Kopen | 15.00 | 4.00 % |
5 februari 2021 | KBC Securities | Hyloris | Kopen | 13.00 | -30.77 % |
7 januari 2021 | Berenberg | Hyloris | Kopen | 15.00 | -22.00 % |
10 september 2020 | KBC Securities | Hyloris | Kopen | 12.00 | -10.83 % |
7 augustus 2020 | KBC Securities | Hyloris | Kopen |
Hyloris verbreedt pijplijn met nieuw kandidaat-product voor Vulva Lichen Sclerosus (VLS)
Hyloris kondigt positieve klinische studieresultaten aan voor Valacyclovir orale suspensie (HY-029)
No Records Found
No Records Found
Resultaten |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Omzet |
0
|
0
|
0
|
0
|
0
|
|
Kosten |
0
|
0
|
4
|
6
|
6
|
7
|
Nettowinst |
0
|
0
|
-4
|
-6
|
-6
|
-7
|
Winstmarge |
0.0
|
0.0
|
-1771.43
|
-6711.11
|
-6411.11
|
-3972.22
|
ROI |
0.0
|
0.0
|
86.71
|
268.44
|
56.62
|
-12.11
|
Balans |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Eigen vermogen |
0
|
0
|
-4
|
-2
|
-10
|
59
|
Vreemd vermogen |
0
|
0
|
9
|
10
|
16
|
10
|
Totaal vermogen |
0
|
0
|
4
|
8
|
6
|
69
|
Solvabiliteit |
0.0
|
0.0
|
-98.17
|
-28.30
|
-170.40
|
85.37
|
Cash |
0
|
0
|
0
|
3
|
0
|
64
|
Kasstroom |
0
|
0
|
-2
|
-5
|
-5
|
-5
|
Werknemers |
0
|
0
|
0
|
0
|
0
|
|
Omzet per werknemer |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
Kasstroom / vreemd vermogen |
0.0
|
0.0
|
-0.19
|
-0.53
|
-0.28
|
-0.45
|
Details |
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|
Koers |
0.0
|
0.0
|
0.0
|
0.0
|
11.70
|
Winst per aandeel |
0.0
|
-1.27
|
-1.79
|
-1.60
|
-0.33
|
Koers / winst-verhouding |
0.0
|
0.0
|
0.0
|
0.0
|
-35.45
|
Dividend |
0.0
|
0.0
|
0.0
|
0.0
|
|
Dividend % |
0.00 %
|
0.00 %
|
0.00 %
|
0.00 %
|
|
Payout % |
0.0
|
0.0
|
0.0
|
0.0
|
|
Boekwaarde |
0.0
|
-0.24
|
-0.13
|
-0.57
|
2.31
|
Boek / koers |
0.0
|
0.0
|
0.0
|
0.0
|
0.20
|
Kasstroom per aandeel |
0.0
|
-0.09
|
-0.30
|
-0.26
|
-0.18
|
Aandelen |
0
|
18
|
18
|
18
|
26
|
Marktkap. |
0,00
|
0,00
|
0,00
|
0,00
|
299,43
|
Datum
|
Koers
|
---|---|
01 mei
|
11.70
|
22 apr
|
11.95
|
18 apr
|
11.95
|
17 apr
|
12.00
|
09 apr
|
12.55
|
05 apr
|
11.65
|
03 apr
|
11.80
|
30 maa
|
11.45
|
22 maa
|
11.10
|
18 maa
|
11.95
|
15 maa
|
12.30
|
12 maa
|
12.85
|
11 maa
|
12.95
|
09 maa
|
12.95
|
07 maa
|
12.20
|
01 maa
|
12.25
|
29 feb
|
12.30
|
27 feb
|
11.75
|
22 feb
|
12.30
|
21 feb
|
12.45
|
20 feb
|
12.80
|
15 feb
|
12.90
|
14 feb
|
12.90
|
13 feb
|
13.10
|
09 feb
|
13.20
|
08 feb
|
13.20
|
07 feb
|
12.80
|
06 feb
|
13.00
|
05 feb
|
13.20
|
01 feb
|
13.25
|